Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -72.45 | -10.16 |
| PEG Ratio (TTM) | 0.55 | -0.36 |
| P/S Ratio (TTM) | 1.07 | 1.16 |
| P/B Ratio (TTM) | 0.98 | 1.71 |
| P/FCF Ratio (TTM) | 71.05 | 30.47 |
| Price to 5YR AVG Earnings Ratio | 8.16 | 23.41 |
| Price to 5YR AVG FCF Ratio | 6.37 | 7.77 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.04% | 3.61% |
| ROE (TTM) | -1.33% | 8.14% |
| Net Profit Margin (TTM) | -1.53% | 4.86% |
| ROIC 5YR AVG | 26.47% | 17.93% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.08% | 237.42% | 115.57% |
| Revenue | -3.67% | 45.09% | 18.81% |
| Net Income | -13.10% | 297.98% | 150.50% |
| Cash Flow | 243.58% | 405.50% | 220.49% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.82 | 2.57 |
| Quick Ratio (TTM) | 1.17 | 1.84 |
| D/E Ratio (TTM) | 0.07 | 1.02 |
| Interest Coverage (TTM) | -4.26 | 10.25 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 3.41 | 2.98 |
| LTL to 5YR AVG FCF | 0.21 | 8.38 |
| Shares Outstanding Growth 5YR AVG | 5.14% | 2.20% |